logo

For the Inventor, By the Inventor

Midland, MI, United States of America

James R McCarthy, Jr

This inventor holds 6 USPTO granted patents. Top assignee: The Dow Chemical Company. Active years: 1976-1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James R McCarthy, Jr. Retrieved from https://idiyas.com/inventor/james-r-mccarthy-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:

goldMedal6 out of 7,680 
 
The Dow Chemical Company
 patents

Years Active: 1976-1978

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4108853 - N,15-Didehydro-15-deoxo-pyrimidino-(4,5-b)rifamycin S (1978-08-22),
2. 4086344 - N,15-Didehydro-15-deoxo-3,15-epi(methano(alkylimino))rifamycins and (1978-04-25),
3. 4029703 - N,N'-disubstituted halophenylacetamidines (1977-06-14),
4. 3975433 - 1-(2,4-Dimethoxy-phenyl)-3-(2-hydroxyethyl)thiourea (1976-08-17),
5. 3972931 - N,N'-Disubstituted benzamidines (1976-08-03),
6. 3969532 - 1-Aryl-3-(2-hydroxyethyl) thioureas for treating depression (1976-07-13),

Title: The Innovative Contributions of James R McCarthy, Jr.

Introduction

James R McCarthy, Jr. is a notable inventor based in Midland, MI (US). He has made significant contributions to the field of chemistry, particularly in the development of antimicrobial compounds. With a total of 6 patents to his name, McCarthy's work has had a meaningful impact on the industry.

Latest Patents

Among his latest patents is the compound N,15-Didehydro-15-deoxo-pyrimidino-(4,5-b)rifamycin S. This compound is prepared through an activated manganese dioxide oxidation of N,15-didehydro-15-deoxo-3,15-epi(methano(imino)rifamycin SV. The new compound demonstrates antimicrobial utility, showcasing McCarthy's focus on health-related innovations. Additionally, he has worked on N,15-Didehydro-15-deoxo-3,15-epi(methano(alkylimino))rifamycins, which can exist in either the quinone or hydroquinone form. These compounds are prepared from the corresponding Mannich base derivatives by an acid-catalyzed dehydration reaction.

Career Highlights

James R McCarthy, Jr. is currently employed at The Dow Chemical Company, where he continues to innovate and develop new chemical compounds. His work at Dow has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Jimmie L Moore and Don V Wysong. Their collaborative efforts contribute to the advancement of chemical research and development.

Conclusion

James R McCarthy, Jr. is a distinguished inventor whose work in antimicrobial compounds has made a significant impact in the field of chemistry. His contributions continue to influence the industry and inspire future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…